Everolimus 5mg
Product Overview
| Generic Name | Everolimus 5mg |
| Brand Name(s) | Afinitor, Zortress, Certican, Votubia |
| Category | Antineoplastic / Cancer |
| Form | Oral tablets 10 tab pack |
| Strength | 5 mg. |
| Therapeutic Class | Kinase inhibitor – oncologic agent |
| ATC Code | L01EG02 |
Manufacturing & Regulatory
| Manufacturer | Novartis, Multiple Generic mfg's |
| GMP Compliance | WHO‑GMP |
| DMF/CEP | Type II |
| Free Sale Certificate | Yes |
Logistics & Export
| MOQ | 5,000 Tabs/500 Packs |
| Shelf Life | 36 months (sealed) |
| Storage | Store below 30 °C in dry environment; protect from moisture |
| Incoterms | FOB / CIF / DDP |
| Lead Time | 2 Weeks |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Upon Request |
| SDS-Safety Data Sheet (PDF) | Upon Request |
| CTD Summary (PDF) | Upon Request |
Special Notes
Indicated for advanced RCC, hormone-receptor+ breast cancer (with exemestane), progressive NETs, TSC-associated SEGA and angiomyolipoma; also immunosuppression post-transplant